Prophase Labs Inc reports results for the quarter - Earnings Summary

Reuters11-13

* Prophase Labs Inc reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents. The lone analyst forecast for the quarter was for earnings of 4 cents per share.

* Revenue fell 62.4% to $3.15 million from a year ago; analysts expected $23.85 million.

* Prophase Labs Inc's reported EPS for the quarter was a loss of 35 cents.

* Prophase Labs Inc shares had fallen by 69.5% this quarter and lost 83.7% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had risen by about 123.5% in the last three months.

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Prophase Labs Inc is 18.50 This summary was machine generated from LSEG data November 13 at 03:23 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 0.04 -0.35 Missed

Jun. 30 2024 -0.24 -0.33 Missed

Mar. 31 2024 -0.28 -0.07 Beat

Dec. 31 2023 -0.26 -0.51 Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483880333?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-13 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483880333","market":"us","top_or_hot":-1,"title":"Prophase Labs Inc reports results for the quarter  - Earnings Summary","media":"Reuters","content":"<html><body><p>* Prophase Labs Inc    reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents.  The lone analyst forecast for the quarter was for earnings of 4 cents per share. </p><p>   * Revenue fell 62.4% to $3.15 million from a year ago; analysts expected $23.85 million. </p><p>   * Prophase Labs Inc's reported EPS for the quarter was a loss of 35 cents.</p><p>   * Prophase Labs Inc shares had fallen by 69.5% this quarter and lost 83.7% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts had risen by about 123.5% in the last three months. </p><p>   * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the healthcare facilities &amp; services peer group is also \"buy\"</p><p>Wall Street's median 12-month price target for Prophase Labs Inc is 18.50  This summary was machine generated from LSEG data November 13 at 03:23 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2024      0.04           -0.35          Missed</p><p>Jun. 30 2024      -0.24          -0.33          Missed</p><p>Mar. 31 2024      -0.28          -0.07          Beat</p><p>Dec. 31 2023      -0.26          -0.51          Missed</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prophase Labs Inc reports results for the quarter  - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProphase Labs Inc reports results for the quarter  - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 23:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Prophase Labs Inc    reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents.  The lone analyst...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRPH","symbol_name":"ProPhase Labs","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2483880333","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483880333","pubTimestamp":1731511454,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Prophase Labs Inc    reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents.  The lone analyst f","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PRPH":"ProPhase Labs"},"translate_title":"Prophase Labs Inc报告季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRPH":0.9},"content_text":"* Prophase Labs Inc    reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents.  The lone analyst forecast for the quarter was for earnings of 4 cents per share.    * Revenue fell 62.4% to $3.15 million from a year ago; analysts expected $23.85 million.    * Prophase Labs Inc's reported EPS for the quarter was a loss of 35 cents.   * Prophase Labs Inc shares had fallen by 69.5% this quarter and lost 83.7% so far this year.FORECAST CHANGES   * The mean earnings estimate of analysts had risen by about 123.5% in the last three months.    * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONS   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"    * The average consensus recommendation for the healthcare facilities & services peer group is also \"buy\"Wall Street's median 12-month price target for Prophase Labs Inc is 18.50  This summary was machine generated from LSEG data November 13 at 03:23 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDSep. 30 2024      0.04           -0.35          MissedJun. 30 2024      -0.24          -0.33          MissedMar. 31 2024      -0.28          -0.07          BeatDec. 31 2023      -0.26          -0.51          Missed","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483880333"}